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ESSENTIAL 'fHROMBOCYTOPENIC PURPURA 
Essential Thranbooytopenic Purpura Hemorrhagica belongs to 
oJJe of the heterogenous groups of affections generally classified 
as belonging to the hemorrhagic diseases; thought as late as the 
beginning o.f the century to be dependent upon a hemorrhagic dia-
thesis, -- diathesis referring to a tendency. inherited or acquir-
ed to bleed -- chiefly from the capillaries. In order that we 
may relegate this condition to a distinct category, let us brief-
ly review the more distinctive features of the affection. 
'fhranbooytopenic Purpura is an affection, proceeding through 
an acute, subacute, or chronic course. characterized clinically 
by hemorrhage into the skin and mucous membranes that cannot be 
controlled by the use of ordinary hemoatatios. 
The condition is usually not hereditary. but congenital 
and familial forms have been described. It occurs chiefly in 
adolescence bpt may occur at alJIY age. The acute attack may ap-
pear, run its course in two or three days eDiing .fatally; or af-
ter two to three weeks may eventually cease as abruptly as it 
began or pass into the subs.cute or chronic stages. 
The condition usually starts with petechial and eoc~otic 
hemorrhages into the skin. - over the entire body in more se-
vere oases• These petechiae also occur in the buccal mucous 
membrane, palate and pharymt. Hemorrhage from the gums. nose, 
and less frequently the stomach, intestines and kidneys are 
480980 
r 
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(2) 
prominent features when present and girls may present menorrhagia 
or metrorrhagia. 
The vulnerability of the capillaries is an outstanding feature 
since the slightest trauma or static resistance (capillaryresis~ance 
test) results in a shower of petecbiae. The contimed loss of 
blood results in a marked anaemia and the patient may become weak. 
incapacitated and bedridden. Remissions are common but exsangui-
nation may eventually result leading to a fatal termination • 
. Fever may be present but usually accompanies the extravasation of 
large amounts of blood where absorption or the blood clots leads 
to byperpyrexia. .A.s Rosenthal (96) describes the typical sufferer 
• - - - - The· pictur~ is that of a young ghastly white, 
blanched faced individual. bedridden• with dried blood crusts on 
the lips, the teeth covered with clotted remnants or blood arising 
tram bleeding gums J and from the noatrils ·may be seen extruding,, 
hemorrhagic clots from which oozes fluid blood which trickles · 
down over the lips. - - - - • 
.Attempts at stopping this bleeding by such ordinary agencies 
as tam.ponage; transfusions, calcium salts, thrombalcinase,, etc •• · 
meet· as a rule with no success. 
Examination of' the blood of these patients give certain 
characteristics of the disease which reveal at least in part,, 
the pathogenesis and individualise it fraa other forms of' purpura. 
First, there is a marked dimunition in the number of plate-
lets, usually from the normal of 2so.ooo to less than 100,000, 
("',. 
more rarely to total absence. It is this characteristic of the 
disease that gifts it the title of Thranbocytopenio purpura. 
(3) 
Secondly, if the blood is permitted to clot, which it does 
in normal time, the clot remains UJU:etracted instead of shrink-
ing from the walls of the tube as it does normally, exuding serum 
as the process occurs. This at once differentiates the condition 
from hemophilia where the clotting time is markedly delayed and 
imperfectly executed, and though, a:t'ter the clot forms, retrac-
tion occurs. 
The third important hematological finding is an increased 
bleeding time -- the time necessary for capillary bleeding to 
cease. Norm.ally, a small puncture wound ceases to bleed tram 
one and a half to three minutes; but in this affection may take 
ten or more minutes before cessation of the capillary oozing. 
In other respects the blood picture shows only compensa-
tory changes as a result of the hemorrhage. The leucocyte 
picture is variable, but a moderate leucocytosis is the rule. 
The red blood cells are usually markedly diminished along with 
the hemoglobin, although there is a hypochramia, the color index 
being less than one. Smears show a tendency for the red cells to be 
m.icrocytic with occasional nonaa.blasts appearing. 
The present accepted classification of Purpura is of'f ered 
by Pratt (92) and Leschke (65). 
I• Thrambocytopenic Purpura 
A. Essential or primary (Werlhof•s disease) 
B • . Symptomatic 
1. In blood diseases (aplastic anaemia. 
leukemia. pernici·ous anaemia) 
2. Infection&. (aepsis. subaeute bacterial 
endocardi tis• typhoid. tuberculosis• etc .• ) 
3. Intoxications (benzol, arsphenamine, 
snake venm., etc.) 
4. Radiation (X-ray,· radium, etc.) 
6. Diseases associated with splenomegaly 
(hemolytic ieterus, Gauoher•s disease, etc.) 
6. Tumors, metastases, sclerosis of the bone 
marrow. 
1. Anaphylaxis 
8. Avitaminoses 
II. Nonthrombooytopenic purpura 
A. Essential or primar,y 
1. .Anaphylaotoid (purpura ot Schonleim 
and Henoch. and er,ythmna of Osler.) 
2. Miscellaneous (purpura simplex, 
purpura fulminans, purpura senilis, 
purpura oachectica, mechanical purpura 
and familial and hereditary purpura) 
Be Symptomatic or secondary Purpura 
1. Various chronic diseases (chronic 
nephritis, cardiac or hepatic diseases) 
(4) 
(5) 
a. Inteetions (scarlet fever. typhoid. etc.) 
s. Intoxications (benzol. arsphenamine• 
iodine. an.alee venom. etc.) 
4. Avitaminoses (scurvy) 
HISTORY 
Essential Thrombocytopenia was first separated from the 
heterogenous group ot purpuras by lferlhof in 1735. Although 
there have been no controversions of his class~cal description. 
still certain additions have been made and other types of purpura 
described. 
In 1883 Krauss {60) reported the observations of Brohm. 
tha.t i;he platelets were markedly reduced in number at the time 
hemorrhage occurred. De~a (20) a trench histologis by independent 
work also observed this phenaaena.. and Hayem. ( 42) not only con-
firmed these observations but demonstrated the role of the plate-
lets in clotting and the non retraotility of the clot in Pur-
pura hemorrhagioa. 
Duke (26) in 1912 reported that the bleeding time was pro-
longed in this affection. He also noted that the purpurio mani-
festations closely followed the platelet count and produced the 
disease in rabbits by reducing the platelet count with diphtheria 
toxin and benzol. 
In short until reeent years. at leastJ the history of 
thram.bocytopenio purpura has paralleled that of the platelet 
and were more known of the physiology of the platelet today. 
more might be known of purpura hemorrhagica. Pure skepticism 
however. finally backed by experimental and clinical data has 
reduced the importance of the thram.bopenia in this affection. 
THE BLOOD PLATELET AND ITS CLINICAL SIGNIFICANCE AS 
ULATED TO TBROMBOCYTOPENIA PURPURA 
The platelet in health may be defined as a round or oval 
disk-like body with an average diameter varying between two and 
three microns,, and with a hyaline cytoplasm containing numerous 
granules. It was discovered as early as the middle of the last 
century by Donne and .Arnold (23) and called "blood platelets" by 
Bizzozero (12). The existence of a third morphological blood 
element has been repeatedly affirmed and denied. Ka.thews (77) 
believed the blood platelet to be merely a precipitate .formed in 
altered blood plasma. Roskam (98) on the other hand showed that 
the particles of precipitated plasma bore no resemblance to 
(6) 
blood platelets in size. shape or staining reactioJlS. Bizzosero 
(13) was the first respol18ible for asserting their imependence as 
blood elements. Hay• (41) and Kemp (56) thought the platelet 
to be erythroblastic in origin and this idea ultimately prevail-
ed until 1906 when .. ight (117) made a comprehensive study ot 
the platelets, their morphology and relation to the myelogenous 
(7) 
tissue. He found the platelets to correspond closely in structure 
to the megokaryocyte of the marrow. having a red and purple gran-
ular central area surrounded by a eyaline blue border. These 
megokaryocytes he found to have paeudopods. segmented at intervals with 
granulated center, h&ving the appearance of a stock of platelets 
connected to the giant cell. It was his conception that these 
pseudopods, extending into the marr.ow sinusoids became broken off, 
the resultant irregular fragments becoming platelets• This work was 
con.i'irmed by Bunting (17) and others. Aschoff (3) considers it 
a closed question. Also, in support of this conception Wright and 
others point out the parallelism between the number of circulating 
blood piatelets and the number of megoka.ryocytes in the bone marrow. 
Both are increased in regenerative states.following on hemorrhage 
and toxemia, in inflammatory states, in :m;yelogenous leukemia (118) 
in Hodgekins disease, in experimental conditions £ollowing the 
innoculation of diphtheria toxin (24) and antiplatelet serum (67). 
More direct proof is ottered by the observations of Sabin (101) 
who watched the clumping of granules and fragmentations of the cy-
toplasm into typical platelets, in megokaryocytes of the bone 
marrow in vital preparation. In same instances, small plate-like 
portions of the cytoplasm. became attached to the peripher.y of 
. the cell by a narrow stalk until ultimately the cytoplasm of 
these cells had become almost completely fragmented into small 
.irregular oval and granular masses lying free in the surrounding 
medium. Bedson and Johnston (6) on the other hand interpreted 
t"'\ 
(8) 
this appearance as degenerative and not productive. Arter inject-
ing antiplatelet serum. they saw no megokaryocytes in the stage 
ot active platelet budding but did note an increased number ~t 
megokaryocytes in the bone marrow which is in support of· wright's 
theor;y. Le Sourd and Pagniez (67} found that like the platelet, 
the megokaryocyte produced retraction of' the clot. concluding a 
genetic relationship between the two. 
It may be added that although these considerations eliminate 
the er;ythrooyte and leuc~cytes as precursors of' the platelets. 
still evidence is not overwhelming in favor of the megokaryocyte. 
This is because most of the evidence is based on morphological 
and tinctorial observations. However it seems reasonable to suppose 
that the platelet is an independent element and has orgin in the 
bone marrow if not other potential hemopoetic tissues in time of' 
stress. (23) 
Like the red blood cells. however, the platelets are supposed-
ly destroyed by the phagocytic action of cells of the reticulo-
endothelial system, a system discovered mainly by the efforts of 
ASchoff (3). In the strict sense. this system. is composed of 
the reticulum cells of the splenic pulp, the cortical nodules and 
pulp cords of the lymph nodes and remainder of lymphoid tissue, 
the reticulum cells of the sinuses of the lymph nodes, the blood 
sinuses of the spleen, the capillaries of the liver lobules 
(Kupffer's cells) and the capillaries of the bone marrow, adrenal 
cortex and hypopeysis. This destruction capacity has been dif'-
(9) 
ficult to demonstrate on h\D'llan beings. The spleen constantly contains 
·1arge numbers of platelets in health and may be seen in the splenic 
sinuses when a portion of that organ is teased out in a suitable 
medium and properly stained (6,7). Spleneotomy, experimental or 
. . . 
therapeutic is followed by an increase in the circulating plate-
lets (6,7) and blood.of the cubital vein and splenic artery contain 
more platelets than blood from the splsnic vein (16). 
In contradistinction it must be rem.EID.bared that an increase 
in platelet count follows other operative·procedures, experimental 
or therapeutic (6,8, 7). Furthermore an increase in the n\D'llbers 
of circulating platelets does not always follow splenectomy (15) 
although spence (102) believes this is due to a. diseased extra-
splenio reticulo-endothelial system. One must also conaider that 
the spleen acts as a reservoir for red blood corpuscles and 
therefore the platelets may be retained for storage purposes and 
not for destruction. Proof is offered here in that injection of 
ephedrine or adrenalin which produces splenio contraction is fol-
lowed by a rise in the number of circulating platelets. 
Some investigators claim to have observed phagocytosis of 
degenerated platelets within the endothelial cells of the spleen. 
It is interesting to note that when the function of the retioulo-
endothelia.l system is "blocked" such as by the injections of 
trypan blue, there is an increased number of platelets in the 
circulation (7, 59, 112). If splenectamy is performed atter 
blocking, the platelet count does not rise :t'urther. However, 
the blocking is only temperarily effective and it may be that 
other tissues take over the tu.notion of the retioulo-endothelial 
syst•• 
It is quite probable that a great number of platelets are 
produced and destroyed each day. Duke (24, 26) found that the 
total number of circulating.platelets could be regenerated 
within three to five days. Ma.okay (76) in counting the plate-
lets of thirty health subjects found the ~ount to range from 
250,.000 to 450,.000 with individual variations amounting to as 
200,.000 in the same day. Thus it would appear that the plate-
(19) 
lets delicate structure a.nd its ease of degeneration and regeneration, 
its life is probably short. 
PATHOGENF.SIS 
The most thought-provoking phenome:na. found in this affection 
·is the thrombopenia, not only because it aids in the differenti-
ations from the forms of purpura, but because it supposedly was 
responsible in 'Whole or in part for the symptomatology and tend-
ed to reveal,. at least in pert, the pathogenesis • 
.Assuming, as 119 must for the present, that the genesis of 
the thrombocyte is from the megokaryocyte of the bone marrow, 
and its doom in the phagocytosis of the reticulum cells, then it 
might be supposed the ultimate cause for such depletion either 
lies in an illhibition of formation or increased destruction at 
• 
{ll) 
these two terminals • 
Frank . (33). professor of Internal Medicine in the University 
of Breslau in 1916 proposed the theory that this thi"ombopenia 
was due to an inhibitory action on the megokaryocytes of the bone 
marrow by a :myelotoxin. Ka.znelson ( 64) on the other hand believ-
ed the spleen to be responsible for an excessi-ve destruction of 
the platelets. In dogmatic fashion he did not believe the con-
dition could exist without the thraabopenia. He.boldly executed 
his theory by removing the spleen on one of his patients with 
phenomenal results. Frank explained Kaznelson 1 s success by sug-
gesting the spleen to be the source of some toxic agent acting 
upon the bone marrow. These two theories have added proponents~and 
up to the present day are still antagonistic. 
The histopathological reports on autopsied material has cer-
tainly added no light to the subject. (83• so. 14. 78. 89. 102, 
196. 36) If permitted to draw 8.JJ¥ conclusions, whatsoever, from 
these reports it shall have to be in generalizations for the 
findings are not constant. In the final analysis. the bone 
marrow reveals an increased number of megokaryooytes and it is 
highly probable that this increase represents a canpensatory 
h¥P•rplasia rather than a pathological state. The spleen, on 
the other hand. gives a rather constant picture of splenitis, 
acute or chronic. 
Experimental and clinical data. however, do not conform 
with the theory that the platelet deficiency is the sole cause 
(12) 
of the purpura. Of primary evidence of this, we have the m.asai ve 
amount of data ccnpiled by Cole (18), Le Sourd and Pagniez (69), 
Ledingham (62, 63), and.Bedson. It was Bedson who finally per-
fected the antiplatelet serum so that it produced no hemagglutin-
ation, and the new antisera, when injected into experimental. ani-
mals was capable or producing purpura. But the pertinent point of 
Bedson's experiments was that aga;r serum injections, which pro-
duced a marked thromboeytopenia did not produce purpura unless 
anti-red cell aera was added. He thus concluded that two condi-
tions were necessary for the production or purpura. 
1. Removal of the platelets from the 
circulation. 
2. Toxic injury to the capillary endothelium.. 
Clinically, the return of a thrombopenia af'ter splenectomy 
without a return of the purpuric manifestations in evidence that 
the thrombopenia is not the sole factor. Furthermore, though 
the purpuric symptoms closely parallel the platelet count in . 
most cases, this is not invariable (82, 113, 102). In a.plastic 
anemia, where all eel lular elements of the blood are all decreas-
ed, along with the platelets, purpura does not occur. }(ackay (76) 
demonstrated that prolonged bleeding could occur in the presence 
or a normal platelet count, and normal bleeding time and the ab-
sence of hemorrhage in the presence of a diminished platelet 
count. 
In the early experimental work it was difficult to reduce 
(13) 
the platelet count without·also injuring the capillary endothelium. 
As has been pointed out, Bedson (9) could considerably reduce the 
platelet count with agar serum., but not produce purpura without 
damaging the endothelium. or the capillaries. 11bittkower (114) 
by means or X-ray-, reduced tb,e platelet count to 19.,000 without 
producing purpura. Pulvertoft (93) on the other hand., by- injecting 
atreptoeoccal toxin into rabbits produced a picture ot fulminating 
purpura without ~ dim.inition in the platelet count. 
Kaznelson (55) and Rosenthol (96) attanpt to explain purpura 
in the presence or normal platelet counts by suggesting a quali-
tative def'ect in the platelet and point out the variation in morph-
ology or the platelet in this condition. Mack~ (76) however could 
find no evidence ot this. He believed the platelet reduction to 
. be on a toxic basis., perhaps from a metabolic or secretory def'io-
ienoy., as in pernicious anaemia where the platelet count is great-
ly increased on liver therapy. According to this theory the plate-
let reduction is merely a superimposed phenomena -- and is probab-
ly due to an interference with normal platelet formation. 
T-idy (108, 109) believes the platelet reductions to be 
secondary to endothelial damage and hemorrhage; ye~ he fails to 
ex.plain Why- in other conditions such as scurvy, where damage to 
the e:api_llary endothelium exists, there is no pronounced thrombo-
cy'bopenia. 
E'V8l18 (28) recording the platelet count following splenectOJ!V 
in a case of thrombocytopenic purpura. found that it took ninety 
days for the count to return to normal limits. He believes 
two factors are responsiblea--
1. The reticule-endothelial syst-. taking 
over the function of the spleen. 
2 • Some toxic agent removed by remaval of 
the spleen. 
However the Nsults of splenect~ are not so constant 
that Evans• theory is applicable to all. Piney (91) divides 
the essential throm.bopenia purpuras into three groups. those 
in which there is: 
1. A rapid rise in platelets to a normal 
level which is sustained. 
2. A rise after operation followed by 
return of purpuric symptoms. 
3. No change in the platelet count though 
there was a marked thrombopenia be-
fore operation. These cases often show 
clinical improvement in spite of the 
platelet count• 
It is quite obvious that the role played by the spleen 
varies in these three groups. In the first group. the spleen 
is evidently responsible for the low platelet count (either be-
cause of marrow inhibition or increased destruction) and the 
purpura. Splenectany would be speci.f'ic in such a .condition. 
In the second group. the fall of the platelet count to former 
levels might be explained on the basis that the rest of the 
(14) 
of the reticule-endothelial system has compensated for the loss 
of the spleen. In the third instance, the spleen was probably 
not the seat of the trouble. 
Lesch.er and Hubble ( 66) believe that the purpuras should 
be divided into two groups depending on the causes:-
1. Deficient production or megolcaryocytes 
~· Defective separation of the platelet 
from.the ~egokaryocyte. 
Possibly a third cause might be mentioned, mainly the excessive 
destruction by the spleen. 
De Sanot.is and Allen (21 )' believe that some agent activates 
the reticulo-endothelial system to unusual thrombolytic activity. 
The fact that splenectany in acute cases has no effect bears 
out this opinion. They believe recurrences due to the fact 
t:m t the reticulo-endothelial system has partially taken over the 
function or the spleen following extirpation or that organ. 
Ask81' and Toland (4), in regards to the rapid rise in the 
platelet count following splenectomy, suggest· the presence in 
the blood stream of a toxin which tends to lower capillary resis-
ta.nee yet is so transient in its effects that a continuous supply 
is necessary for sustained action. They believe the spleen to 
be the source of the supply since that organ is the only one to 
{15) 
be cut oft from the general circulation in thereapeutic splenectoll\Y• 
Yet D18JJiY cases ahwwing clinical improvement with relief of hanorrhage 
(16) 
after surgical rem.oval of the spleen,, fail to show improvement of 
the blood picture,, the platelets remaining low,, the bleeding time 
prolonged,, the tourniquet teat positive and the clot non-retrac-
tile. They thus conclude that the whole reticulo-endothelial sys-
tem is involved and that the removal of the spleen is only a 
quantitative reduction in the extent of the disease. 
'Whatever the etiological agent may be. it still remains 
obscure. although recent advances may clarit,y the situation to 
quite an extent. Whipple (113) and Tocantis (110) are impressed 
with the fact that infection often precedes the onset of purpuric 
symptoms and Stewart (105) believes that bacterial toxins stimu-
late the reticulo-endothelial system to increased destruction 
of the platelet. These observation have led to the eradication 
of all foci of infections as a supportive measure,, an importaue ad-
junct to all therapeutic procedures. 
The most enlightening work however has just been received 
from Troland and Lee (111) who took the spleen of three patients 
with Thranboeytopenic purpura directly from the operating roan,, 
chopped each into small pieces and placed them in acetone reagent• · 
The supernatant fluid was drained off after a few weeks,, the 
residue shaken with distilled water and filtered. Injection of 
the filtra't;e into rabbits in all three cases produced a reduction 
in theplatelet count £ran 650,,000,, 640,,000,, and 610,,000 to 
58.000,, 10.000 and 100,000 respective4' in twenty four hours. 
Repeated injections caused the platelet count to remain low but 
(17) 
no purpura was evident. The red and white cell counts were not 
appreciably changed. They suggest the name •thrombocytopen" for 
the unknown active principle. As a control. four organs from 
npn-purpuric patients including the spleen of a patient with 
hemolytic icterus. were treated likewise 'but produced virtually 
no decrease in the platelet count. The report. however. is 
preliminary and will be followed by a more complete report in 
the near future. 
BLEEDING TI.ME AND CAPILLARY PERMEABILITY 
With such pertinent facts as supplied by Bedson (9) we know 
that the platelet alone is not responsible for the purpuric mani-
festations. -- and this will be further substantiated in the 
forthcoming discussion. We must assume that the toxic agent 
acts directly upon the endothelial lining of the blood vessels. 
As we have stated. Pulvertoi'ti (93) has shown that a fulminating 
purpura can be produ~ed inthis way without &Jl1 thrombocytopenie.. 
Duke (24) pointed out the relation of' spontaneous capillary 
hemorrhage, bleeding t.iae and the number of' ciruclating plate-
lets. Accordingly. he :touDd that the bleeding time and the pur-
pura were inversely related to the number _of' platelets• He 
discovered that purpura rarely occurred when the platelet count ex-
ceeded 40.000. lt was a natural assumption to regard the thrombo-
cytopenia as the cause of the purpura. Evidence of this relation-
ship exists in other diseases such as acute leukemia. pernicious 
anaemia. diptheria. hemorrhagic small pox. and in such experi-
mental work with diptheria toxin (5. 53) benzol (7) and anti-
platelet serum. (10). Duke believed.the platelets adhered to the 
edges of the injured endothelium. thus closing the wound and 
preventing hemorrhage. 
Frank (33) in 1913 stated that a normai in&act capillary 
will not permit diapedesis or hemorrhage with resultant purpura. 
He believed that there must be scae damage• or at least an in-
creased povosity of the capillaries. The capillary resistance 
test of Ress (43) impresses us with the same idea. ll~rmally 
af'ter a tourniquet has been firmly applied to the upper extrem-
ity so that the venous r_eturn but not the arterial supply is 
obstructed, petechiae do not appear distal to the tourniquet. 
In thrombocytopenia. however, small capillary hemorrhages ap-
pear below the point of constriction. Such bleeding is produc-
ed by an increase in the venous pressure. 
The pathology is not definitely known. Rouget (99) in 
1873 first called attention to the existence of peculiar con-
tractile cells on the walls of the capillaries. Aschoff (3) 
de~ed that these cells were contractile but stated they were 
part of the reticul-endothelial system. Whipple (113) states it 
(18) 
is conceivable to suppose. since the cells of Rouget belong to a 
system stimulated by the same agent ·as other parts of the retioulo-
endothelial system, then the~e cells might be responsible for 
the disturbed permeability of the capillary walls. allowing 
the passage of blood into the tissues. Aschoff believes that 
there is some softening of the intra-cellular cement substance• 
Bedson (9) describes the typical vascular lesion present 
in all cases of Thrombocytopenic purpura. Histological exami-
nation revealed changes in the vascubr endothelium. similar to 
(19} 
those described by Findley for experimental scurvy; namely a. 
swollen edematous appearance of those cells. He placed the 
mesenteric vessels of an anaesthetized guinea pig under observation 
and experimentally prod,uced purpura by i?Ulooulation of anti-
platelet serum. ·Within a short time hemorrhages were observed 
under the microscope along the course of the vessels. yet there 
was no appreciable slowing of the current nor plugging of the 
vess.els. The majc:irity of the hemorrhages appeared to be an 
exaggerated form of diapedesis. Bedson suggests that the hemorr-
hage pr"obably would no-t occur with an adequate number of plate-
lets for the platelets and the white blood cells flowing at the 
periphery would block the escape of the centrall.7 moving red 
cells. were the blood stream appreciabq slowed by the SirOllen 
endothelium it might be argued that the platelets. adhering to 
to the lining cells would eventually plug the vessels and lead 
-to its rupture. However there is not much evidence to support 
this view. 
Kemperer (57) did find this to be the case in four oases of 
clinicalq acute thrcmbocytopenic purpura. The vascular lesions 
{2D) . 
appearing in the capillaries and smaller arterioles. The af-
fected vessels were dilated and the lumen completely occluded 
with granular thrombi. The lining endothelium at these sites 
showed swelling anq proliferation and in JD8.I\Y' places the thrombus 
showe actual invasion with proliferating endothelial cells resemb-
ling houng fibroblasts. Various stages of organization could be 
seen in the same organ. some thrombi were still. mural. They be-
lieved the vascular thrcmbosus occurred in repeated attacks and 
the endothelial proliferation to be a response to the throm.bolytio 
occlusion of the lumen. In ten other cases of acute and seven of 
chronic thrombocytopenic purpura no such pathology could be 
observed. These investigators believe the depletion of plate-
lets to be due to the w.st number composing the thrombi, a theory 
that is similar to that of Tidy {108). It was int.-esting to note 
that a brother of one of the four cases cited above also had 
purpura, clinically identical but no such pathology was observed. 
The vaso-constriction action, concomitant with hemorrhage. 
has long been known. Al early as 1869. Ludwig {75) and Schmidt, 
perfusing the muscle of a dog with blood serum, encountered an· 
unexpected resistance to the flow of defibrinated blood. Early 
investigation believed the effective element to be epinephrin. 
O'Connor {84) however found that the action of the serum was not 
the same as for epinepbrin and that the stimulating agent entered 
the blood during the process of clotting. Janeway and Park {49) 
con£irm.ed this. O'Connor {84) also mentioned that extracts of 
(21) 
of platelets produced a powerful -vaso constrictor action on the 
~rterial ring. Stewart and Tucker (103, 104) appended a _foot note 
to this effect, for it fitted in with their findings, offering 
a relation between the vaso constricting action of the serum an:l 
the formed elements of the blood. These investigators .found 
that the pressor action was due· to a substance formed when the 
fonned elements of the blood were shed. This change occurred 
concomitantly with some of the changes preliminary to clotting 
and nob as the .fibrinogen was converted into fibrin. Their results 
also implied that the vaso constrictor effect of the serum was 
an important adjunct in the role of sealing of important vessels. 
Janeway, Richardson and Park (49) verified the findings of o•eon-
nor that the extracts of platelets produced a powerful vaso constric-
tion action but~could produce no such effect with the extract of 
erythrocytes or leucooytes. Since the circulating plasma of nor-
mal animals produce no vaso constriction and since plasma can 
be taken from the vessels without vasoconstriotion occurring, 
they were -led to conclude "bha.t the substance responsible was 
liberated after the plasma escapes from.the blood vessel. 
Hirose (44) found that the effect of defibrinated blood on 
the carotid artery was roughly proportional to the platelet 
count. In cases 'Where the pla"belet count was extremely low, the 
defibrinated blood had little or no vaso constricting property. 
Tha:t there is a relation between capillary tone and the blood plate-
lets seems to be true. Furthermore, loss of capillary tone leads 
{22) 
to increased capillary leakage. 1fe may thus conclude that aey- great 
quantitative or qualitative change in the platelet preventing the 
supply of vaso constrictor substance would encourage the loss of 
vasomotor tone and the production of capillary hemorrhage. 
McLean (78) on the other hand• states that the severity of 
capillary bleeding is not in proportion to the number of plate-
lets. severe bleeding occurring in the presence of platelet counts 
varying from 10.000 to 140.000. He believes the lowered capillary 
resistance to be due to the activity of the same agent responsible 
for the change in quality or number of platelets and also for the 
irritation of Rouget'a cells and the softening of the intracell-
ular cement substance of the capillary walls. -.ckq {76) fully 
agrees with McLean due to variations in his own oases where no 
hemorrhage occurred when the platelet count on two patients were 
14.000 and 40.000 respectively. The constancy with which the low 
platelet count parallels the bleeding time is due both to vascu-
lar permeability and platelet reduction. Lescbke (65) states that 
the contraction of the capillaries is absent or diminished in 
purpµra and Mackay thinks that the hemorrhage is due tothe inabil-
ity of the walls to contract. Bermuth (11). on the other hand• 
observed norm.al capillary response in this disease. It is quite 
obvious that more experimental work will have to be done on this 
point before its relative importance am be properly evaluated. 
I""'·. 
CL<J.r RETRACTION 
Normally when whole blood is taken from a.vein before it 
has mixed with 81.lY tissue juices, and allowed to stand in a 
container, it becomes gel-like in consistency after two to 
six minutes so that the container can be inverted without 
spilling the blood. Soon the agglutinum. begins to retract 
fran the edge of the vessel, exuding serum as the process oc-
curs. Under standard conditions, this process is complete in 
eighteen hours. 
{23) 
In essential thrombocytopenic purpura hemorrhagica, the 
clotting time is normal, but retraction is either delayed or does 
not occur. The normal clotting time and failure of retraction was 
first noted by Hayen (42) in 1896. Glanzmann (38, 39), LeSourd and 
P&gniea {70) believed a platelet ferment to be the cause because 
platelets were the only blood elements to undergo decompostion 
during the process of coagulation. Frank (34) thought retraction 
to be due to shrinkage of the platelets. The process of coagu-
lation is an intricate phenomenan and not clearly understood in 
spite of vast amounts of research. At present Howell's theory (45) 
of coagulation is accepted. Briefly, the theory states that the 
circulating plasm.a. contains three essential £actors of coagulation, 
fibrinogen, prothrombin, and calcium salts. Coagulation is 
prevented because prothrombin is kept inactive, even in the pres-
ence of the calcium ion by an inhibitory substance, heparin. 'When 
blood is shed without coming into contact with the tissue,, the 
platelets degenerate and liberate a tbromboplastic substance re-
lated to cephalin which neutralizes heparin and allows pro-
thrombin to be converted into the active principle,, thrombin. 
The fibrinogen then reacts with the thrombin to form a firm 
deposit of fibrin crystals which in vivo prevents further es-
cape of blood. 
Reuben a.nd Clemens (95) state that blood deprived of its 
platelets content will not clot unless tissue extracts or 
platelets are added. Brill and Rosenthal (14) believe that 
the failure of clot retraction is due to a qualitative change 
in the platelet. 
The failure of syneresis to occur has also been noted 
in pernicious anemia, a.plastic anemia, and Banti's disease 
(97) where the platelets fall below 100,,000. If a splenecto:my 
is performed,, the clot retracts coincident; with the platelets 
increase (19,, 107,, 84). 
It has been experimentally shown that retraction occurs in 
proportion to the number of platelets in blood plasma. (70) or 
in hydrocoele fluid (71). Furthermore in animals that have been 
deplatetized there is a failure of clot retraction until the 
platelet count; returns to nona.al (62,, 64 ),, then two agents 
which modify or destroy platelets likewise affect. syneresis (70,, 
72). 
Wide variations in relation to retraction and the platelet 
(24) 
(25) 
count have been clinically reported (113. 19) but this variation 
is probably due to errors in laborator,y technique. This is large-
ly due to an adhesive property between the clot and its container 
preventing retraction when, under standard conditions, retraction 
would occur (46, 90). :V.ckay (76) believes this relation of 
platelet and retraction doubtful due to variance in his own cases. 
Archard and ~ (2) found that blood which was deplate-
tized with gelatin, gum and lecithin injections, retracted. 
This has also been noted af'ter deplatelizationwith peptone and 
thymus nucleic acid (90). 
Le Sourd and Pagniez {7S) found that a cha:iige in the l.wdro-
gen ion concentration, by addition of calcium, caused retraction 
which was known to be absent at the time of experimentation, 
demonstrating that the plasma is an important factor. 
Howell, (46) found tmt when the blood was increasingly 
alkalinized, a point; could be reached when the fibrinogen became 
transparent yet which would not retract. Furthermore free oxy-
lated plasm.a or pure fibrinogen showed marked retraction proper-
ties when thranbin was added and Howell believes the platelet 
may be a source of this material. 
Mackay (76) believes that the retraction property of blood 
is inherent in the plasma, and that the platelet only augments 
this property". Thus we must assume that where no retraction occurs, 
there is a· fundamental alteration in the plasma. Tocantis (110) 
is quite in sympatI:w with this theory and believes that syneresis 
(26) 
is not dependent upon the platelet al'though this element promotes 
retraction and prevents adhesion between clot and container. 
DIAGNOSIS 
To mention that th.a diagnosis ahould be assured before the 
more radical types of treatment are resorted to, perhaps seems incon-
sequential. yet the mistake has been made more than onoe of 
subjecting a patient to splenectan;,y when the affection turned 
out to be a JDY'&logenous leukemia in an a.leukemic phase. The 
differential diagnosis should never be lightly considered. Chief-
ly among 'the affections to be eliminated are:-
1. Hemophilia 
2. Aplastio anaemia 
3. Leukemia 
The diagnosis .from hemophilia·can be made on the basis of 
non-traumatic origin of bleeding,, lack of familial history, 
normal clotting time, prolonged bleeding time, absence of clot 
retraction and thrombocyt9pen1a. In acute aplastic anaemia all 
elements of the blood are depleted. There are no nucleated reds 
and there is a decisive leukopenia whereas in the thrombocytopenic 
purpura,, aleucocytosis is the rule. The chief diagnostic poin1;, 
in leukemia is the presence of young white cells ixi the blood. 
Not only the diagnosis of typical cases but also the recog-
nition of atypical case will give the practiilioner much dif'fi-
I'"\ 
culty. Recognition of new groups within the general heading 
of Essential thrombocytopenic purpura. is to be expected at a 
tuture date. Some cases appear to be hereditary or familial. 
Prolongation of the bleeding time without paucity of the plate-
let has been described. Furthe~ study will be necessary be~ore 
a correct subdivision can be accurately made. 
(&?) 
The types of t reatmene for thrombocytopenic purpura are 
~ and varied~ To a great extent therapy depends upon the 
phase and severity of the disease,, the age of the patient,, degree 
of exse.nguination,, etc. For practical purposes we may divide 
the treatment into conservative and radical,, i.e.,, non~operative 
and operative. 
transfusions seem to be the most popular type of conserva-
tive therapy. Larrabee {6l),J0 nes (~,, Moffat (81) and Tacantis 
(110) report cases where repeated trans.f'usions have produced 
remissions without subsequent recurrences~ Such treatment. 
however, is .tr from being uniformly successful, but when 
effective, controls hemorrhage,, increases the red cells and 
platelets and in general is a valuable supportive measure even 
when not curative. 
Other conservative mthods have been tried with varying 
degrees of success. Jones (52) recommends the administration 
I"": 
of calcium. or parathonnone. Dixon (22) reports four cases 
treated successfully with autogenous blood. Liver therapy has 
been tried suceesstully with Jacob (47) and Jones (52). Pan-
coast. Pendergrass, &Ild Fitz Hugh (85) believe that roentgen 
rays should be given for temporary relief. Rudisill {100) 
treated 6 cases with x-ray--producing rapid relief in each case 
and no remissions. Mettier~ stone, and Perviance (79) treated 
five cases wi.th X-ray and found the platelets to rise as much 
(28) 
as 250,000 or 500,,000 in nine days. McLean, et. al. {78) treated 
six cases wi.th ultra violet. Four or the cases were chronic 
&Ild two,, clinically acute. or these six. one died due to ina-
bility to find a donor for transfusion; but the rest suffered 
no recurrences during the entire period of observation (eight 
months to five and one half years), and the platelet count re-
mained within normal limits in three cases for over two years. 
Jones (51) and Giffin {37) also recommends its use and believes 
that a high vitamin B and D diet should be administered to these 
patients. Thramboplastin has also been tried therapeutically (51) 
&Ild non-specific .protein shock: with horse serum., milk and human 
blood ha:ire been tried with a lesser degree of success (30). 
The use of anti-venom as a therapeutic agent has also came 
into limited use by certain clinicians. Taylor {107) reported 
rapid recovery in four of five patients treated with antivenan,, 
and recommends its use in f'ulminating cases where splenectcmw 
carries such a high mortality rate. feck (87) expresses the 
view that the action of a.ntivenom is on the capillaries and the 
mechanism of coagulation. Ir this is so. the et.feet should be 
(and is) temporary. and thus like other forms of conservative 
therapy is not curative but produces remission of symptonu;. 
Peck and Rosenthal (88) treated 13 cases with antivenom and found 
nine cases showed improvement. with symptomatic and hemotological 
relief in four. F~r cases showed only slight temporary relief. 
Rosenthal {88) however. believes that the remissions may be 
spontaneous. He concludes that th±s type of ther~py is of aid 
(29) 
in shortening the period of conve.lescense in patients in the early 
stages of a remission. Gr~enwald (4') had similar success and 
recommended it along with transfusions to be used before splen-
ectomy and in cases where operative procedure did not actively 
curtail the hemorrhagic diathesis. 
SplenectOJ'l\Y has long been the treatment of choice in this 
affection since Kaznelson firs~ achieved his brilliant results. 
Eliason and Ferguson {27) in 1932. reporting two hundred thirteen 
cases in literature. including those canpiled by Whipple (113) 
and Spence (102) and five of their own. give the following results. 
The total mortality rate prior to 1932 was 13.1%, a reduction 
of 7% for the t'.igures given prior to 1928. There were 81.2% of 
the operated cases cured or definitely improved • 
.Among the acute cases, there was a total mortality rate of 
34.3%. However, the .figures .for the period between 1928 and 
1932 were only 13.6% in comparison to that o.f 83.3% reported by 
(30) 
Spence in 1938. 
In the chronic cases. there was a mortality rate of' 7% for the 
whole series against a 11.8% mortality rate reported by Spence. 
In these cases there was cure or improvement in 88.l" of the cases • 
.Among the acute cases all but one died on the operating 
table following operation. In all probability these patients were 
well exsanguinated a.t the time 0£ operation. The phenomenal de-
cline in the mortality in these cases is expained by Eliason and 
Ferguson as due to earlier surgery and more adequate preparation 
'tiefoi'e surgery. 
The above statistical data proves conclusively that the 
chronic oases are better surgical risks than the acute ones. 
But just what to call a chronic or an acute case of' purpura 
hemorrhagica is often difficult to ascertain. 'Whipple (113) states 
that a ct,ae is chronic when the patient has recurrent attacks of 
bleeding from the gums and nose. peteehiae and ecchymoses. men~ 
orrhagia in women, but no bleeding into the alimentary c8.D&l or 
parenclJ¥ma, of the internal organs. Because splenectomy produces 
a cure in these cases•he believes they represent a true disturb-
ance of the reticulo-end.othelial system -- a system in which the 
spleen pl81's a major role • 
. Spence (102). Fib. Hugh (31). and Jones (50) as well as 
others a.re in agreement with this theory. Williamson limits 
operation to those cases in which the patients development and 
health are interferred with or where the bleeding is so profuse 
{31) 
as to endanger the patients life. 
Giffin (35) offers the following results of splenect~ 
at Mayo Clinic and draws his own conclusions. He believes that 
chronic ca.sea of mild severity should be treated symptomatically, 
with elimination offoci of infection, diet, iron and transfusion 
if necessary. In twenty five cases of moderate and severe chronic 
cases operated at Mayo•s, the mortality rate was zero. But re-
currences occurred in seven cases which, for the most part, were 
mild. In nine cases of acute exaceriations of chronic purpura, 
there was only one death, and that due to an intracranial hemorr-
hage before operation. All had mild recurrences.but are well. 
Giffin believes the patient should be given every opportunity 
for spontaneous remission before splenectom;y is resorted to. 
He believes it doubtful if patients, showing acute exacerbations 
can be cured by splenecto:my if they do not respond to transfusion. 
On the other hand if transfusions do not produce a response, 
operation should not be delayed longer than is mcessary. In the 
acute cases he believes that splenectci>m¥.is only indicated when, 
in spite of transfusions,, etc., that patient is on a down-hill 
course. This is probably the general at1?itude at present among 
medical men. However, the trend is definitely toward splenecto:my 
regardless of the chronioity. 
,,,... .. 
(32) 
. CASE REPORT 
A white schoolgirl. age nine. entered the University 
Hospital on February 28, 1938. Two weeks prior to Christmas, 
1937. while convalescing from a sore throat and cervical ade-
nitis, small, slightly elevated black spots spontaneously appear-
ed on the hips. arms, and legs. These areas gave the appearance 
of bruise marks although there was no history of trauma. A few: 
days before Christmas the patient had three spontaneous nose 
bleeds of moderate severity and another on Christmas day,. which 
lasted several hours and lett her pale and :weak. Her physician. 
seeing her for the first time, ordered her to bed and gave her a 
high vitamin C diet., believing the condition to be scurvy. She 
improved considerably until January 3. 1938, when the bluish 
spots reappeared spontaneously over the entire body and the 
temperature rose to 102 degrees. On January 17, she bad another 
severe nose bleed and fainted. She was immediately transfused. 
She suffered three recurrences the following m.onth. including 
hemorrhage from the nose and gums, and a transfusion was the 
method of treatment in each case. Ordinary hemostatics seemed 
useless in attempts to curtail the hemorrhage. . On Februar,y 21., 
she received the fourth t~ansfusion. Since that date she has 
shown considerable improvement, the skin bas cleared, and she 
has had no more active bleeding. She was sent into the University 
hospital by her physician with a diagnosis of Essential Thrombo-
oytopenic purpura. 
No hereditary nor familial relationship could be found in 
the history. She had had pneumonia., small pox, measles, mumps, 
chicken pox, pertussis, and frequent sore throats accompanied 
by cervical adenitis. 
On entrance, the patient was well nourished but very pale. 
There were blood crusts in the external nares and the nasal 
mucous membrane was dry and crusted. The lips were pale and 
the gums had a purplish tinge. There were two carious teeth. 
The tonsils were large and moderately inflammed and thtre was 
a moderate bilateral submaxillary adenitis. The lungs were 
clear. A faint systolic murmur was audible over the apex of 
the heart and there was a questionable enlargement of the heart 
to the left. The spleen was not palpable but percussion showed 
it to be enlarged and subsequ~nt X-rays of the abdomen gave the 
impression that it was twice normal size. 
(33) 
There was no active bleeding. A bluish discoloration over the 
right iliac crest measured 10Jt4 om. There were also ecchymotic 
spots in the right anti-cubital fossa and on the right thigh. 
The tourniquet test was strongly positive, the bleeding time 
prolonged--(7iminutes)1 the platelet count only 96,0001 and 
no clot retraction in the face of a norm.al clotting time of ten 
minutes. 
Dr. Hamilton thought it advisable to pursue a conservative 
course to allow for observation and thorough hematological studies. 
r. 
The patient was placed on a general diet and givenan additional 
six ounces of orange juice a d81'• 
As can be seen from the aocomp8.J7¥ing table. the platelet 
count slowly tell to the low level or 40.000, yet no bleeding 
occurred. The tourniquet test was strongly positive, however. 
and the least trauma produced ecchymosis. On March 11. she 
was transfused with 300 cc. or citrated blood, but though the 
red cells showed a substantial increase, th.8 platelet count re-
mained ~ltered and the bleeding time prolonged. On the 
16th, reticulogenwaa pegan and following a latent period or 
three days the platelet count jumped to 102,000. This rise in 
all probability should be interpreted as a spontane~us remis-
sion tor a week later the count dropped.to a new low level or 
32,000. On the 26th, she had a nasal hemorrhage and vomited 
twice, the vcmitus containing bright red blood. 
On March 3oth, following surgical consultation it waa 
decided to ~o one more conservative attempt,-thia time with 
moccasin venom. Af't;er the first administration the bleeding 
time increased 'bo two hours. but the platelet count remained 
around the same precarious level. The following dq she had 
a slight nasal hemorrhage and there was a persistent oozing 
until April 3, when whe was again transfused andthe snake venom 
discontinued. There has been no bleeding since transfusion. 
She will probably be transfused once again a.Di then splenect~ 
will be performed. 
(34) 
The case is quite typical of an acute thrombocytopenic pur-
pura which has now passed into the chronic phase. It is this 
type of case most amendable to treatment by aplenectonw. and 
since her physical condition is excellent at present. operation 
should result in marked relief or cure. 
(35) 
DATE PLATELETS Ti.B.C. R.B.C. Rb % Ret.% 
2-28-38 96,000 
--------- ----------
--- ---
~-1-38 102.000 6.900 2.280.000 36 ---
3-2-38 98.000 9,850 
---------
--- ---
::Z:-~-~A 91-000 10.050 
---------
---
2.7 
3-4-38 75,000 7,200 2,440,000 32 2.2 
r.r:_i::_ozo ~A - ()()() R _ c:;()n 2.1 
---------
---
3-7-38 66.000 -----
---------
--- ---
I 3-8-38 68,000 
-----
---------
---
1.8 
i 3-9-38 64,000 8,300 
---------
---
2.3 
3-10-38 54,000 
-----
---------
39 
---
I 3-11-38 Ind~rect Blood Transf'usion---300 cc. Citrated Blood 
3-12-38 54.000 8.550 3.580.000 47 2.9 
3-14-38 54,000 
------
--------- ---
1.7 
3-15-38 46,000 
------
---------
---
1.2 
3-16-38 46,000 7,650 3,900,000 52 .8 
3-16-38 ieticuloe:en-~ cc / dav I wpo started. 
3-17-38 40,000 
-----
---------
--- ---
3-18-38 42.000 10,550 3.350.000 58 . 8 
3-19-38 102,000 8,850 3,550,000 56 . 8 
3-20-38 
-------
7,350 3,320.000 64 
---
3-21-38 98,000 7,200 3,270,000 50 .8 
3-22-38 126,000 
-----
---------
---
... s_ 
I 
BLEEDING --
TI?~ 
71?; minutes 
----------
7~ minutes 
----------
----------
----------
----------
8 minute~ 
----------
----------
-----------
-----------
-----------
-----------
% minutes 
----------
----------
----------
----------
----------
CLC1rTING --
TIME 
10 minutes 
----------
----------
----------
----------
----------
----------
?A ,.,,;.,.,,,+"IJ:: 
----------
----------
---------·-
----------
----------
----------
----------
----------
----------
----------
-
------·----
----·-----
,.-...._ 
C1'I 
()) 
..._, 
DATE PLATELETS Tl. B. C. 
~-?~-~R ~!; . ()()() 
------
3- ?A- 38 38 . 000 6. 850 
3-25- 38 38. 000 
------
~-?~-~Q 32 .. 000 
------
3- :!7- 38 
------
13. 4000 
~-?A-~R 36. ()()() 
-------
3 - 29- '>,R 38-000 
-------
'Z 'Z()- 'Z Q I Reticuloger dir.continued . 
3-30-38 36 .. 000 12, 200 
3- 31-38 40 . 000 
------
4-1-38 42. . 000 ------
--
.4.- ?- 'ZO ------ ------
4- 3- 38 Tndirect Rl<l od Transfusion 
A.-L-~R "'4. • ()()() 14.200 
A - "' '2:0 56 . 000 
------
4- 6- 38 88 .. 000 13 .. 600 
4- 7- 38 76. 000 
------
R.B . C. 
Hb " 
Ret .% BLBED!.NG --T!.A!E 
---------
---
l . O 
------------
3,490, 000 
---
1.0 
------------
---------
---
1. 7 
------------
---------
---
1.3 
------------
3 . 470. 000 
--- ---
------------
---------
---
1 . 3 
------------
---------
---
1 . 2 
------------
:Moccasin Venom began. 
3, 410, 000 48 
---
2 hours 1-~ min 
----------
--- ---
16"! minutes 
----------
---
_2_._~_ ~_lminutes 
-
-
----------
---
1 . 5 
-----------
-- 350 OC e -- I i trat"'d Blood 
4_._310, 000 68 
---
14~ minutes 
3. 370, 000 64 ~ .l 7~ minutes 
3, 2ci0,, 000 65 2 . 9 ~minutes 
---------
---
2. 9 7~ minutes 
CL<Jl'THJG --
TIME 
-----------
-----------
-----------
-----------
----·-------
-----------
--------·---
. 11 minutes 
7.1.. minutes 
_ .2 
!7i minutes 
4 minutes 
--------~ 
~minutes 
4 minutes 
4 minutes 
,.......,. 
CA 
---1 
-...J 
) 
.ADDITION.AL LABORATORY DATA 
Sedimentation Rate: 24 mm. in 1 hour and 23 minutes. 
Fragility Test: · FrClll .4% Na Cl to .18% Na Cl. 
Kahn and Kline (diagnostic)r Negative 
Ditterential Blood Counts Segmented forms----------39 
start-------------------- 2 
Eosinophiles--~---------- l 
Monocytes----~------~----10 
~hocytes--------------48 
•Subsequent diftereIItiala, in search of young white cells 
not recorded. No immature cells fou:nd. 
Blood Sllleara Reveals variation in size and shape ot the red cells w.ith a prepon-
deranee of microcytesJ moderate achromia and slight polyohromasia. 
No abnormal white cells. 
) J 
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